Corline Biomedical Issues 2026 Financial Forecast and 2027 Guidance

Corline Biomedical AB issued a full-year 2026 financial forecast and market guidance for 2027, based on recently received orders and customer forecasts. The company said the disclosure is intended to clarify its long-term growth potential and was made under the EU Market Abuse Regulation. The article provides no specific financial figures or stock-price impact.